| 000 | 00884 a2200253 4500 | ||
|---|---|---|---|
| 005 | 20250512195348.0 | ||
| 264 | 0 | _c19811122 | |
| 008 | 198111s 0 0 eng d | ||
| 022 | _a0140-6736 | ||
| 024 | 7 |
_a10.1016/s0140-6736(81)92788-4 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSherrard, D J | |
| 245 | 0 | 0 |
_aRoyal College of Physicians of Endinburgh. _h[electronic resource] |
| 260 |
_bLancet (London, England) _cSep 1981 |
||
| 300 |
_a644 p. _bdigital |
||
| 500 | _aPublication Type: Letter | ||
| 650 | 0 | 4 | _aBenzothiadiazines |
| 650 | 0 | 4 | _aDiuretics |
| 650 | 0 | 4 |
_aKidney Calculi _xprevention & control |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 |
_aSodium Chloride Symporter Inhibitors _xtherapeutic use |
| 773 | 0 |
_tLancet (London, England) _gvol. 2 _gno. 8247 _gp. 644 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0140-6736(81)92788-4 _zAvailable from publisher's website |
| 999 |
_c6116210 _d6116210 |
||